CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc. (CERO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CERO · as of Jun 9, 2026
Key Statistics
Explore CERo Therapeutics Holdings, Inc. Data
cero stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
cero competitorsCERO
BCTXZ
BIVI
ELAB
GLMD
LIMNStock Performance
Full HistoryAbout CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-123…
what is cero therapeutics holdings, inc. · cero stock overview · cero therapeutics holdings, inc. company profile · who is cero therapeutics holdings, inc. ceo · cero OTC · cero therapeutics holdings, inc. headquarters · cero therapeutics holdings, inc. business segments
About Stock Overview & Key Data
CERo Therapeutics Holdings, Inc. (CERO) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 30, 2021. As of the latest trading session, CERO stock price is $0.01, with a market capitalization of $12,596. The stock has returned -99.87% over the past 12 months and -84.39% year-to-date.
According to 1 Wall Street analysts, the consensus rating for CERo Therapeutics Holdings, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, CERo Therapeutics Holdings, Inc. reported revenue of — and net income of -$19.9M. For detailed data — including CERo Therapeutics Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CERo Therapeutics Holdings, Inc. (CERO) stock price is $0.01. The stock is traded on OTC under the ticker symbol CERO. The 52-week range is $0.01 – $26.99.